当前位置:首页 - 行情中心 - 海辰药业(300584) - 财务分析 - 现金流量表

海辰药业

(300584)

  

流通市值:42.61亿  总市值:62.27亿
流通股本:8211.51万   总股本:1.20亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金313,542,042.48151,327,782.5500,092,543.2367,639,384.2
  收到的税费返还11,216,039.6911,216,039.6929,488,306.5829,488,306.58
  收到其他与经营活动有关的现金1,648,650.961,251,757.442,348,713.481,400,501.53
  经营活动现金流入小计326,406,733.13163,795,579.63531,929,563.26398,528,192.31
  购买商品、接受劳务支付的现金18,349,449.7510,117,367.4250,615,347.3638,908,197.89
  支付给职工以及为职工支付的现金37,288,297.4321,127,895.8970,723,431.855,371,255.36
  支付的各项税费48,179,255.4223,395,327.1176,024,694.0560,182,587.68
  支付其他与经营活动有关的现金156,951,984.4265,995,687.82274,605,948.23200,120,983.63
  经营活动现金流出小计260,768,987.02120,636,278.24471,969,421.44354,583,024.56
  经营活动产生的现金流量净额65,637,746.1143,159,301.3959,960,141.8243,945,167.75
二、投资活动产生的现金流量:
  收回投资收到的现金1,000,344.951,000,344.952,003,517.811,001,808.22
  处置固定资产、无形资产和其他长期资产收回的现金净额29,180,406.065,464.55,3925,392
  投资活动现金流入小计30,180,751.011,005,809.452,008,909.811,007,200.22
  购建固定资产、无形资产和其他长期资产支付的现金39,258,022.7127,151,835.7577,936,524.6559,564,648.76
  投资支付的现金9,100,0009,100,0002,000,0001,000,000
  投资活动现金流出小计48,358,022.7136,251,835.7579,936,524.6560,564,648.76
  投资活动产生的现金流量净额-18,177,271.7-35,246,026.3-77,927,614.84-59,557,448.54
三、筹资活动产生的现金流量:
  吸收投资收到的现金--16,500,000-
  其中:子公司吸收少数股东投资收到的现金--16,500,000-
  取得借款收到的现金115,500,00065,500,000273,500,000205,500,000
  收到其他与筹资活动有关的现金18,600,00010,000,00074,336,273.1445,600,483.33
  筹资活动现金流入小计134,100,00075,500,000364,336,273.14251,100,483.33
  偿还债务支付的现金101,200,00060,100,000260,100,000179,000,000
  分配股利、利润或偿付利息支付的现金15,820,205.411,927,039.5913,851,109.9911,840,264.15
  支付其他与筹资活动有关的现金39,089,174.1515,910,915.2673,472,372.2253,270,150
  筹资活动现金流出小计156,109,379.5677,937,954.85347,423,482.21244,110,414.15
  筹资活动产生的现金流量净额-22,009,379.56-2,437,954.8516,912,790.936,990,069.18
四、汇率变动对现金及现金等价物的影响21,764.186,711.27-8,688.23-1,882.67
五、现金及现金等价物净增加额25,472,859.035,482,031.51-1,063,370.32-8,624,094.28
  加:期初现金及现金等价物余额45,758,717.8345,758,717.8346,822,088.1546,822,088.15
  期末现金及现金等价物余额71,231,576.8651,240,749.3445,758,717.8338,197,993.87
补充资料:
  净利润28,878,476.75-40,162,971.25-
  资产减值准备8,635,020.7-9,049,612.26-
  固定资产和投资性房地产折旧13,526,764.15-27,767,967.59-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,526,764.15-27,767,967.59-
  无形资产摊销14,879,581.42-25,161,216.66-
  处置固定资产、无形资产和其他长期资产的损失-482,279.37---
  固定资产报废损失332,529.09-291,206.3-
  财务费用3,447,312.21-8,871,901.68-
  投资损失1,225,456.46--3,318.69-
  递延所得税-5,894,949.34--5,790,680.08-
  其中:递延所得税资产减少-1,662,683.22--3,651,076.82-
    递延所得税负债增加-4,232,266.12--2,139,603.26-
  存货的减少-1,685,688.6--13,441,920.84-
  经营性应收项目的减少-4,122,420.6--49,871,785.88-
  经营性应付项目的增加6,669,810.12-17,762,971.57-
  现金的期末余额71,231,576.86-45,758,717.83-
  减:现金的期初余额45,758,717.83-46,822,088.15-
  现金及现金等价物的净增加额25,472,859.03--1,063,370.32-
公告日期2025-08-232025-04-212025-04-212024-10-26
审计意见(境内)标准无保留意见
TOP↑